Phibro Animal Health Corporation is dedicated to helping meet the demand for animal protein. The company concentrates exclusively on animals for food production, and it is one of the few global companies offering a comprehensive range of animal health and mineral nutrition products. Phibro Animal Health develops, manufactures, and markets a broad range of products for food animals including poultry, swine, beef and dairy cattle, and aquaculture, with direct sales and technical teams in 16 countries and R&D/manufacturing sites in the United States, Brazil, and Israel. Phibro Israel manufactures active pharmaceutical ingredients in Neot Hovav; produces vaccines in Beit Shemesh, and produces pharmaceuticals, disinfectants and other animal health products in Petach Tikva. Also operates Animal Health R&D and product testing in Beit Shemesh, Neot Hovav, and Maayan Tzvi. It was established in 2009 with the acquisition of Abic's animal vaccine division from Teva Pharmaceuticals. In 2014, Phibro acquired the aquaculture assets of AquaVet Ltd, a technical consulting and contract research organization focused on the global aquaculture market. Phibro' pHi-Tech business unit of poultry vaccination management is also operating in Israel.